Prevention of cardiovascular (CV) disease represents a pillar of contemporary medicine, as CV diseases are the most frequent cause of death and disability and a heavy socioeconomic burden. This is a concise and practical book that provides internationally applicable evidence-based standards of good practice. It discusses major advances in diagnosis and therapy. It continues to emphasize the importance of secondary prevention to reduce the recurrence of myocardial infarction, stroke, etc., improving the sustainability of the healthcare system.
Key Features:
- Explains the importance of preventing cardiovascular diseases and evidence-based prevention methodologies
- Discusses the role of pharmacological interventions in the primary and secondary prevention of cardiovascular diseases, relevant for both clinicians and trainees.
- Shows how primary prevention can be achieved through non-pharmacological and dietary interventions.
Prevention of cardiovascular (CV) disease represents a pillar of contemporary medicine, as CV diseases are the most frequent cause of death and disability and a heavy socioeconomic burden. This is a concise and practical book that provides internationally applicable evidence-based standards of good practice.
Chapter 1: Current views on the burden of cardiovascular disease CHAPTER
2: Strategy of interventions and targets at individual and population levels
CHAPTER 3: Cardiovascular prevention in children and adolescents CHAPTER 4:
Non modifiable risk factors CHAPTER 5: Modifiable-Risk factors CHAPTER 6:
Additional and emerging risk factors CHAPTER 7: Subclinical Organ Damage
CHAPTER 8: Stratification of Cardiovascular Risk in Practice CHAPTER 9:
Individual Genetic Assessment for analyzing the risk of cardiovascular
diseases CHAPTER 10: Clinical approach to cardiovascular prevention in the
general practice CHAPTER 11: Prevention of cardiovascular risk factors in
children and adolescents CHAPTER 12: Non pharmacological interventions
CHAPTER 13: Pharmacological interventions CHAPTER 14: Secondary Prevention
CHAPTER 15: Tertiary Prevention and Rehabilitation
Massimo Volpe is Emeritus Professor of Sapienza University of Rome and Professor of Cardiology Department of Clinical and Molecular Medicine, Sapienza University of Rome. He is President of the Italian Society of Cardiovascular Prevention and a member of the Scientific Committee of the Italian Society of Hypertension and is a scientific consultant at IRCCS San Raffaele in Rome. He is the former Dean of the Faculty of Medicine and Psychology and Deputy Rector for Research Planning at the University of Rome Sapienza. He has been Assistant Professor at New York Hospital-Cornell University Medical College, National Coordinator of the Research Evaluation Process for the Area of Medicine (VQR) Ministry of University and Research and a member of the National Committee for Research Supervision (CNGR). He was conferred the 2021 Peter Van Zwieten Award for Research European Society of Hypertension.
Professor Volpes primary research interests are neurohormonal control of circulation and cardiovascular structural and functional abnormalities in hypertension and heart failure. He is a Fellow of the American Heart Association (High Blood Pressure Council), and European Society of Cardiology, and a Hypertension Specialist of the European Society of Hypertension. He has served as President of the Italian Society of Hypertension and of the Italian College of Cardiology.
Professor Volpe has authored more than 1000 publications in prestigious cardiovascular, peer-reviewed, international journals with an H-index of 108 and more than 106,570 citations. He has lectured in major international congresses and at leading universities worldwide and has served on the editorial boards of major cardiovascular journals.
